U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07248839) titled 'A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment' on Nov. 18.
Brief Summary: The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepatic function and participants with different degrees of hepatic impairment
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Hepatic Impairment
Intervention:
DRUG: BMS-986435
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Publish...